The U.S. Food and Drug Administration is cracking down on companies selling alternative versions of blockbuster weight-loss drugs. On Tuesday, the agency issued warning letters to 30 telehealth ...
Compounded tirzepatide contains the same active ingredient as Mounjaro, but its dosage and some ingredients may differ from Mounjaro. The Food and Drug Administration (FDA) does not regulate the ...
On Wednesday, pharmaceutical giant Eli Lilly sued four prominent telehealth companies that offer more affordable, off-brand versions of its patented best-selling GLP-1 medications Mounjaro and ...
Compounding pharmacies will have to stop producing copycats of tirzepatide, the active ingredient in the blockbuster weight loss drugs Mounjaro and Zepbound, in a matter of days. That’s because a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results